The patient burden of nocturnal polyuria in the United States: Results from the epidemiology of nocturnal polyuria (EpiNP) study

被引:4
|
作者
Chapple, Christopher R. R. [1 ]
Rosenberg, Matt T. T. [2 ]
Mueller, Elizabeth R. R. [3 ]
Chughtai, Bilal [4 ]
Weiss, Jeffrey P. P. [5 ]
Juul, Kristian [6 ]
Brooks, Anne B. B. [7 ,8 ]
Bacci, Elizabeth D. D. [9 ]
Andersson, Fredrik L. L. [6 ]
Coyne, Karin S. S. [8 ,10 ]
Bosch, J. L. H. Ruud
机构
[1] Univ Sheffield, Sheffield Teaching Hosp NHS Fdn Trust, Dept Urol, Sheffield, England
[2] Mid Michigan Hlth Ctr, Dept Family Med, Jackson, MI USA
[3] Loyola Univ Med Ctr, Dept Obstet Gynecol & Urol, Div Female Pelv Med & Reconstruct Surg, Maywood, IL USA
[4] Weill Cornell Med Coll, Dept Urol, New York, NY USA
[5] SUNY Downstate Hlth Sci Univ, Dept Urol, Brooklyn, NY USA
[6] Ferring Pharmaceut AS, Global Value & Access, Copenhagen, Denmark
[7] Patient Ctr Res, Bethesda, MD USA
[8] Evidera, Bethesda, MD 20814 USA
[9] Evidera, Patient Ctr Res, Seattle, WA USA
[10] Evidera, Patient Ctr Res, Bethesda, MD 20814 USA
关键词
health-related quality of life; nocturnal polyuria; patient burden; survey; work productivity; WORK PRODUCTIVITY; IMPACT; VALIDITY; QUALITY;
D O I
10.1002/nau.25126
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo explore the impact of nocturnal polyuria (NP) on health-related quality of life (HRQoL), work productivity, mental health, fatigue, bother, and daytime sleepiness. Materials and MethodsThis large-scale, US population-representative epidemiologic study was conducted in two parts: a web-based survey and 3-day bladder diary. Consenting participants completed the baseline Epidemiology of NP (EpiNP) survey online (Lower Urinary Tract Symptoms [LUTS] Tool, comorbidities, burden, and multiple HRQoL measures). Participants who reported >= 2 voids/night, and a random sample of 100 respondents each reporting 0 or 1 void/night, were sent urine measurement containers and asked to complete the 3-day bladder diary. NP was defined as Nocturnal Polyuria Index >0.33 (NPI33) or nocturnal urine production >90 ml/h (NUP90). Five subgroups were created: Idiopathic NP (NP with no underlying cause), NP associated with symptoms of overactive bladder (NPOAB) or bladder outlet obstruction (NPBOO; men only), NP associated with other comorbidities (NPCOM; e.g., diabetes, hypertension, heart disease, sleep apnea), and no NP (did not meet NP criteria). ResultsA total of 4893 men and 5297 women completed the EpiNP survey; mean age was 54.4 (SD = 14.7). Significantly greater patient burden (p < 0.0001) was evidenced in the nocturia group (>= 2 voids/night) versus no nocturia group (0-1 void/night) on daily impact of nocturia, LUTS Bother, prostate symptoms (men only), work productivity, physical and mental health component scores, depression, fatigue, and daytime sleepiness. NP subgroup analyses showed men in the NPBOO group and women in the NPOAB group reported the greatest impact on LUTS bother, fatigue, physical health, work productivity impairment, daytime sleepiness, and depression (women only). ConclusionThis was the first large-scale, epidemiologic study to explore the impact of different forms of NP on patients' HRQoL. Findings demonstrate that NP associated with other urologic or comorbid conditions appears to have greater patient burden than idiopathic NP, in particular for women.
引用
收藏
页码:573 / 585
页数:13
相关论文
共 50 条
  • [1] The Prevalence of Nocturnal Polyuria in the United States: Results from the Epidemiology of Nocturnal Polyuria Study
    Weiss, Jeffrey P.
    Bosch, J. L. H. Ruud
    Chapple, Christopher R.
    Bacci, Elizabeth D.
    Simeone, Jason C.
    Rosenberg, Matt T.
    Mueller, Elizabeth R.
    Andersson, Fredrik L.
    Juul, Kristian
    Chughtai, Bilal
    Coyne, Karin S.
    EUROPEAN UROLOGY FOCUS, 2022, 8 (05): : 1415 - 1423
  • [2] Nocturnal polyuria in women: results from the EpiNP study
    Mueller, Elizabeth R. R.
    Weiss, Jeffrey P. P.
    Bosch, J. L. H. Ruud
    Chughtai, Bilal
    Rosenberg, Matt T. T.
    Bacci, Elizabeth D. D.
    Simeone, Jason C. C.
    Andersson, Fredrik L. L.
    Juul, Kristian
    Coyne, Karin S. S.
    Chapple, Christopher R. R.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2023, 34 (08) : 1743 - 1751
  • [3] Nocturnal polyuria in women: results from the EpiNP study
    Elizabeth R. Mueller
    Jeffrey P. Weiss
    J. L. H. Ruud Bosch
    Bilal Chughtai
    Matt T. Rosenberg
    Elizabeth D. Bacci
    Jason C. Simeone
    Fredrik L. Andersson
    Kristian Juul
    Karin S. Coyne
    Christopher R. Chapple
    International Urogynecology Journal, 2023, 34 : 1743 - 1751
  • [4] Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose titration study
    Asplund, R
    Sundberg, B
    Bengtsson, P
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (05): : 642 - 646
  • [5] Nocturia and Nocturnal Polyuria in Neurological Patients: From Epidemiology to Treatment. A Systematic Review of the Literature
    Haddad, Rebecca
    Denys, Pierre
    Arlandis, Salvador
    Giannantoni, Antonella
    Del Popolo, Giulio
    Panicker, Jalesh N.
    De Ridder, Dirk
    Pauwaert, Kim
    Van Kerrebroeck, Philipp E.
    Everaert, Karel
    EUROPEAN UROLOGY FOCUS, 2020, 6 (05): : 922 - 934
  • [6] Desmopressin (melt) therapy in children with monosymptomatic nocturnal enuresis and nocturnal polyuria results in improved neuropsychological functioning and sleep
    Van Herzeele, Charlotte
    Dhondt, Karlien
    Roels, Sanne P.
    Raes, Ann
    Hoebeke, Piet
    Groen, Luitzen-Albert
    Vande Walle, Johan
    PEDIATRIC NEPHROLOGY, 2016, 31 (09) : 1477 - 1484
  • [7] An exploratory pilot study with copeptin as a biomarker for individualizing treatment for nocturnal polyuria
    Bruneel, Elke
    Goessaert, An-Sofie
    Denys, Marie-Astrid
    Juul, Kristian V.
    Norgaard, Jens P.
    Everaert, Karel
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2019, 11 (01) : 43 - 47
  • [8] Do independent geriatric outpatients with nocturnal polyuria profit from desmopressin?
    Weinrebe, W.
    Kaebe-Frisch, S.
    Fuesgen, I
    Karaman, M.
    Johannsdottir, E.
    Rupp, S.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2019, 52 (03): : 272 - 278
  • [9] Pharmacokinetics and Pharmacodynamics of the Oral Disintegrating Tablet of Desmopressin in Adults with Nocturnal Polyuria: A Pilot Study
    An-Sofie Goessaert
    Karel Everaert
    Piet Hoebeke
    Johan Vande Walle
    Advances in Therapy, 2015, 32 : 799 - 808
  • [10] Pharmacokinetics and Pharmacodynamics of the Oral Disintegrating Tablet of Desmopressin in Adults with Nocturnal Polyuria: A Pilot Study
    Goessaert, An-Sofie
    Everaert, Karel
    Hoebeke, Piet
    Vande Walle, Johan
    ADVANCES IN THERAPY, 2015, 32 (09) : 799 - 808